HUP9903115A2 - Vizes közegben duzzadó mátrixban legalább egyféle gyógyászati hatóanyagot tartalmazó orális készítmény - Google Patents
Vizes közegben duzzadó mátrixban legalább egyféle gyógyászati hatóanyagot tartalmazó orális készítményInfo
- Publication number
- HUP9903115A2 HUP9903115A2 HU9903115A HUP9903115A HUP9903115A2 HU P9903115 A2 HUP9903115 A2 HU P9903115A2 HU 9903115 A HU9903115 A HU 9903115A HU P9903115 A HUP9903115 A HU P9903115A HU P9903115 A2 HUP9903115 A2 HU P9903115A2
- Authority
- HU
- Hungary
- Prior art keywords
- swelling
- aqueous medium
- active pharmaceutical
- preparation containing
- oral preparation
- Prior art date
Links
- 230000008961 swelling Effects 0.000 title abstract 3
- 239000012736 aqueous medium Substances 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- 239000011159 matrix material Substances 0.000 title abstract 2
- 239000010410 layer Substances 0.000 abstract 2
- 229920000856 Amylose Polymers 0.000 abstract 1
- 239000012790 adhesive layer Substances 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000000758 substrate Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Orális készítmény, amely legalább egyfajta gyógyászati hatóanyagőttartalmazó, vizes közegben dűzzadó mátrixőt tartalmaz és ez ahatóanyag a mátrixból annak dűzzadása sőrán időben elnyújtőttanszabadűl fel a vizes közegbe, miközben e felszabadítás sőránmesszemenően ellenáll a szétesésnek, amelyre jellemző, hőgy akészítmény egymásra tapadó rétegekből álló réteges tabletta, amelybenleglaább egy réteget az említett mátrixréteg képez, legalább egytővábbi réteg pedig segéd- és/vagy hőrdőzóanyag réteg, mimellett adűzzadó mátrixréteg a hatóanyag mellett térhálósítőtt amilózt istartalmaz. ŕ
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19640062A DE19640062B4 (de) | 1996-09-28 | 1996-09-28 | Orale Zubereitung, enthaltend in einer in wässrigem Medium quellbaren Matrix wenigstens einen pharmazeutischen Wirkstoff |
Publications (3)
Publication Number | Publication Date |
---|---|
HUP9903115A2 true HUP9903115A2 (hu) | 2000-02-28 |
HUP9903115A3 HUP9903115A3 (en) | 2000-03-28 |
HU227865B1 HU227865B1 (en) | 2012-05-29 |
Family
ID=7807265
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9903115A HU227865B1 (en) | 1996-09-28 | 1997-08-29 | Oral preparation containing at least one active pharmaceutical substance in a matrix capable of swelling in an aqueous medium |
Country Status (23)
Country | Link |
---|---|
US (1) | US6238698B1 (hu) |
EP (1) | EP0946150B1 (hu) |
JP (1) | JP2001504807A (hu) |
KR (1) | KR100493139B1 (hu) |
CN (1) | CN1139378C (hu) |
AT (1) | ATE213933T1 (hu) |
AU (1) | AU724802B2 (hu) |
CA (1) | CA2260845C (hu) |
CZ (1) | CZ291258B6 (hu) |
DE (2) | DE19640062B4 (hu) |
DK (1) | DK0946150T3 (hu) |
ES (1) | ES2174296T3 (hu) |
HU (1) | HU227865B1 (hu) |
IL (1) | IL129171A (hu) |
MY (1) | MY130959A (hu) |
NO (1) | NO991477L (hu) |
NZ (1) | NZ333401A (hu) |
PL (1) | PL188392B1 (hu) |
PT (1) | PT946150E (hu) |
SI (1) | SI0946150T1 (hu) |
SK (1) | SK282709B6 (hu) |
WO (1) | WO1998013028A1 (hu) |
ZA (1) | ZA978625B (hu) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR030557A1 (es) * | 2000-04-14 | 2003-08-27 | Jagotec Ag | Una tableta en multicapa de liberacion controlada y metodo de tratamiento |
US8487002B2 (en) * | 2002-10-25 | 2013-07-16 | Paladin Labs Inc. | Controlled-release compositions |
TWI319713B (en) * | 2002-10-25 | 2010-01-21 | Sustained-release tramadol formulations with 24-hour efficacy | |
US20060172006A1 (en) * | 2003-10-10 | 2006-08-03 | Vincent Lenaerts | Sustained-release tramadol formulations with 24-hour clinical efficacy |
CA2491665A1 (fr) * | 2004-12-24 | 2006-06-24 | Louis Cartilier | Formulation de comprime pour liberation soutenue de principe actif |
BRPI0615860B8 (pt) | 2005-09-09 | 2021-05-25 | Labopharm Barbados Ltd | composição farmacêutica de liberação prolongada monolítica sólida |
US20080286343A1 (en) * | 2007-05-16 | 2008-11-20 | Dzenana Cengic | Solid form |
US8226967B2 (en) | 2008-11-27 | 2012-07-24 | Basf Se | Surface active proteins as excipients in solid pharmaceutical formulations |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1237904B (it) | 1989-12-14 | 1993-06-18 | Ubaldo Conte | Compresse a rilascio a velocita' controllata delle sostanze attive |
CA2041774C (en) * | 1990-11-27 | 1994-04-19 | Mircea A. Mateescu | Use of cross-linked amylose as a matrix for the slow release of biologically active compounds |
US5603956A (en) * | 1990-11-27 | 1997-02-18 | Labopharm Inc. | Cross-linked enzymatically controlled drug release |
WO1994002121A1 (en) * | 1992-07-24 | 1994-02-03 | Labopharm Inc. | Cross-linked polyhydroxylic material for enzymatically controlled drug release |
US5616343A (en) * | 1993-03-25 | 1997-04-01 | Labopharm, Inc. | Cross-linked amylose as a binder/disintegrant in tablets |
DE4341442C2 (de) | 1993-12-04 | 1998-11-05 | Lohmann Therapie Syst Lts | Vorrichtung zur kontrollierten Freisetzung von Wirkstoffen sowie ihre Verwendung |
DE4416926C2 (de) | 1994-05-13 | 2000-01-13 | Lohmann Therapie Syst Lts | Verfahren zur Herstellung von Vorrichtungen zur kontrollierten Freisetzung von Wirkstoffen |
IT1282650B1 (it) * | 1996-02-19 | 1998-03-31 | Jagotec Ag | Compressa farmaceutica,caratterizzata da elevato aumento di volume a contatto con liquidi biologici |
WO2007095324A1 (en) | 2006-02-14 | 2007-08-23 | The Procter & Gamble Company | Personal care compositions comprising responsive particles |
-
1996
- 1996-09-28 DE DE19640062A patent/DE19640062B4/de not_active Expired - Fee Related
-
1997
- 1997-08-29 AU AU46193/97A patent/AU724802B2/en not_active Ceased
- 1997-08-29 CZ CZ19991013A patent/CZ291258B6/cs not_active IP Right Cessation
- 1997-08-29 SI SI9730331T patent/SI0946150T1/xx unknown
- 1997-08-29 WO PCT/EP1997/004717 patent/WO1998013028A1/de active IP Right Grant
- 1997-08-29 EP EP97944810A patent/EP0946150B1/de not_active Expired - Lifetime
- 1997-08-29 ES ES97944810T patent/ES2174296T3/es not_active Expired - Lifetime
- 1997-08-29 AT AT97944810T patent/ATE213933T1/de active
- 1997-08-29 PT PT97944810T patent/PT946150E/pt unknown
- 1997-08-29 DK DK97944810T patent/DK0946150T3/da active
- 1997-08-29 DE DE59706576T patent/DE59706576D1/de not_active Expired - Lifetime
- 1997-08-29 KR KR10-1999-7002366A patent/KR100493139B1/ko not_active IP Right Cessation
- 1997-08-29 US US09/147,974 patent/US6238698B1/en not_active Expired - Fee Related
- 1997-08-29 CN CNB97198204XA patent/CN1139378C/zh not_active Expired - Fee Related
- 1997-08-29 IL IL12917197A patent/IL129171A/en not_active IP Right Cessation
- 1997-08-29 SK SK387-99A patent/SK282709B6/sk unknown
- 1997-08-29 HU HU9903115A patent/HU227865B1/hu not_active IP Right Cessation
- 1997-08-29 JP JP51519098A patent/JP2001504807A/ja active Pending
- 1997-08-29 NZ NZ333401A patent/NZ333401A/en not_active IP Right Cessation
- 1997-08-29 CA CA002260845A patent/CA2260845C/en not_active Expired - Fee Related
- 1997-08-29 PL PL97332577A patent/PL188392B1/pl not_active IP Right Cessation
- 1997-09-25 MY MYPI97004477A patent/MY130959A/en unknown
- 1997-09-26 ZA ZA9708625A patent/ZA978625B/xx unknown
-
1999
- 1999-03-26 NO NO991477A patent/NO991477L/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE269709T1 (de) | Tablette mit verzögerter freigabe enthaltend einen blutzuckersenkenden wirkstoff und einen antihyperglyzemischen wirkstoff | |
AU610112B2 (en) | Tablet for pharmaceutical use able to release active substances at successive times | |
PL329285A1 (en) | Pharmaceutic tablets of controllable active substance release containing an active substance carrier based on crosslinked amylase and hydroxypropylmethylllcellulose | |
GR3003031T3 (en) | Granule remaining in stomach | |
EP0356382A3 (de) | Mehrschichtiges Pflaster | |
ITMI922617A1 (it) | Forme matriciali multistrato per il rilascio controllato di principi attivi | |
FI944035A (fi) | Tramadolisuolaa sisältävä lääkeaine, jolla on viivästynyt vaikuttavan aineen vapautuminen | |
ZA977832B (en) | Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents. | |
AU1023788A (en) | Therapeutic system for sparingly soluble active ingredients | |
AU3268689A (en) | Transdermal monolith systems | |
ES2182397T3 (es) | Comprimido para la liberacion instantanea y prolongada de una o mas substancias activas. | |
NZ298994A (en) | Drug dosage form containing a core having at least two layers, both containing a polymer that forms microscopic gel beads upon hydration but only one contains the drug and an impermeable, insoluble coating containing apertures which provide for the hydration and release of the beads | |
IL129171A0 (en) | Oral preparation containing at least one active pharmaceutical substance in a matrix capable of swelling in an aqueous medium | |
MY111126A (en) | Transdermal therapeutic system comprising the active substance acetylsalicylic acid. | |
NO970610L (no) | Sammensetning for selektiv frigjöring av en aktiv ingrediens | |
CA2283408A1 (en) | Swallow tablet comprising paracetamol | |
DK0615442T3 (da) | Solreguleret termokolloidmatrix på gelatinebasis til perorale former med retarderet frigivelse. | |
EP0070127A3 (en) | Tablets | |
WO1994025025A3 (de) | Systeme zur kontrollierten abgabe von pilocarpin | |
ES8603262A1 (es) | Perfeccionamientos en formas farmaceuticas solidas para uso oral | |
EP0974361A4 (en) | METHOD OF USING AN ANTI-ACID AGENT AND PHARMACEUTICAL PREPARATION CONTAINING THE SAME | |
DE3772954D1 (de) | Arzneimittel mit verzoegerter wirkstoffabgabe. | |
HUP9902681A2 (hu) | Térhálósított amilózt és hidroxi-propil-metil-cellulózt tartalmazó hordozóval készült szabályozott felszabadulású tabletta gyógyszerkészítmény | |
IT1275267B (it) | Forme farmaceutiche a rilascio modificato di canrenoato di potassio costituite da matrici idrofile rivestite | |
AU4015097A (en) | Transdermal therapeutic system having an active compound combination comprising oestriol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of definitive patent protection due to non-payment of fees |